OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. META
6. SPY
7. ACN
8. PRIM
9. PFE
10. TSLA

Go back to OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.26 +0.26 (2.60%)
Previous Close $10.00    52 Week High $2.18 
Open $10.04    52 Week Low $0.30 
Day High $10.30    P/E N/A 
Day Low $10.03    EPS $-3.32 
Volume 101,870       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.26 +0.26 (2.60%)
Previous Close $10.00    52 Week High $2.18 
Open $10.04    52 Week Low $0.30 
Day High $10.30    P/E N/A 
Day Low $10.03    EPS $-3.32 
Volume 101,870